Advertisement
Screener

XERIS PHARMACEUTICALS INC Form D

XERIS PHARMACEUTICALS INC Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2013-07-10: Federal exemption Rule 506; Types of securities offered Debt; SecurityToBeAcquired; Date of first sale 2012-05-25; Total offering amount $3,000,000.
  • 2013-02-14: Federal exemption Rule 506; Types of securities offered Debt; SecurityToBeAcquired; Date of first sale 2012-05-25; Total offering amount $3,000,000.
  • 2012-09-25: Federal exemption Rule 506; Types of securities offered Debt; SecurityToBeAcquired; Date of first sale 2012-05-25; Total offering amount $3,000,000.
  • 2012-06-08: Federal exemption Rule 506; Types of securities offered Debt; SecurityToBeAcquired; Date of first sale 2012-05-25; Total offering amount $3,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2013-07-10
D/A
Rule 506Debt; SecurityToBeAcquired2012-05-25$3,000,000$2,315,000$685,00038
2013-02-14
D/A
Rule 506Debt; SecurityToBeAcquired2012-05-25$3,000,000$1,750,000$1,250,00028
2012-09-25
D/A
Rule 506Debt; SecurityToBeAcquired2012-05-25$3,000,000$1,125,000$1,875,00020
2012-06-08Rule 506Debt; SecurityToBeAcquired2012-05-25$3,000,000$225,000$2,775,0006
2011-10-12
D/A
Rule 506Equity; OptionToAcquire; SecurityToBeAcquired2011-07-05$1,958,748$1,837,848$120,90019
2011-07-19Rule 506Equity; OptionToAcquire; SecurityToBeAcquired2011-07-05$1,958,748$1,298,748$660,00017